NovoCure NVCR reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
NovoCure missed estimated earnings by 56.25%, reporting an EPS of $-0.5 versus an estimate of $-0.32.
Revenue was down $15.37 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06 which was followed by a 1.67% drop in the share price the next day.
Here's a look at NovoCure's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.30 | -0.26 | -0.15 | -0.18 |
| EPS Actual | -0.36 | -0.25 | -0.23 | -0.04 |
| Revenue Estimate | 128.25M | 131.94M | 134.99M | 134.08M |
| Revenue Actual | 128.43M | 131.00M | 140.87M | 137.55M |
To track all earnings releases for NovoCure visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
